Latest Period
Q2 2026
Security Snapshot
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACCW) Institutional Ownership
CUSIP: G6717R112
13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026
Institutions Reporting
28
Shares (Excl. Options)
2,828,361
Price
$0.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A ordinary shares, par value $0.0001 per share
- Symbol
- OACCW on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 2,828,361
- Total 13F value
- $2,650,830
- Portfolio coverage rank
- 0%
- Share change
- +33,804
- Value change
- +$43,294
- Number of holders
- 28
- Shares outstanding
- 19,607,843
- SEC-reported price per share
- $0.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- OACCW - Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share is tracked under CUSIP G6717R112.
- 28 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 28 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,066,215 to $2,650,830.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 28 institutions filings for Q2 2026.
Security key
G6717R112
Latest holder period
Q2 2026
13F holders
28
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
OACCW full holder history
Oaktree Acquisition Corp. III Life Sciences SEC filings
Oaktree Acquisition Corp. III Life Sciences company facts
Oaktree Acquisition Corp. III Life Sciences insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G6717R112:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
OACCW
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 6.2% | $898,402 | 1,228,500 | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2026 | |||
| Fort Baker Capital Management LP | 5.1% | $750,000 | 1,000,000 | Fort Baker Capital Management LP | 31 Mar 2026 |
As of 30 Jun 2026, 28 institutional investors reported holding 2,828,361 shares of Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACCW). This represents 14% of the company’s total 19,607,843 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
14%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.7% | 340,000 | 0% | 0% | $323,000 |
| AQR Arbitrage LLC | 1.4% | 282,120 | 0% | 0% | $251,087 |
| TORONTO DOMINION BANK | 0.97% | 189,816 | +9.6% | 0% | $178,617 |
| Walleye Capital LLC | 0.86% | 169,502 | 0% | 0% | $159,569 |
| Decagon Asset Management LLP | 0.83% | 162,702 | 0% | 0.03% | $153,168 |
| BOUSSARD & GAVAUDAN GESTION SAS | 0.77% | 150,000 | 0% | 0.02% | $133,500 |
| JPMORGAN CHASE & CO | 0.74% | 145,000 | 0% | 0% | $129,050 |
| Weiss Asset Management LP | 0.74% | 144,767 | 0% | 0% | $137,529 |
| Linden Advisors LP | 0.61% | 120,000 | 0% | 0% | $126,600 |
| BNP PARIBAS FINANCIAL MARKETS | 0.54% | 105,907 | 0% | 0% | $99,701 |
| MOORE CAPITAL MANAGEMENT, LP | 0.54% | 105,000 | 0% | 0% | $98,847 |
| Shaolin Capital Management LLC | 0.51% | 100,625 | -11% | 0.01% | $94,728 |
| Alberta Investment Management Corp | 0.51% | 100,000 | 0% | 0% | $94,140 |
| LMR Partners LLP | 0.48% | 95,000 | 0% | 0% | $89,433 |
| Periscope Capital Inc. | 0.46% | 90,000 | 0% | 0.01% | $84,726 |
| GRITSTONE ASSET MANAGEMENT LLC | 0.4% | 78,981 | 0% | 0.07% | $74,353 |
| Lineage Point Capital LP | 0.4% | 78,928 | 0.02% | $74,303 | |
| ExodusPoint Capital Management, LP | 0.31% | 60,000 | 0% | 0% | $56,484 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 0.31% | 60,000 | 0% | 0% | $56,484 |
| WHITEBOX ADVISORS LLC | 0.26% | 50,000 | 0% | 0% | $47,070 |
| Sculptor Capital LP | 0.26% | 50,000 | 0% | 0% | $47,070 |
| DLD Asset Management, LP | 0.23% | 44,519 | 0% | $41,910 | |
| K2 PRINCIPAL FUND, L.P. | 0.21% | 40,369 | +3.4% | 0% | $37,947 |
| Verition Fund Management LLC | 0.12% | 23,790 | -2.3% | 0% | $22,601 |
| Schonfeld Strategic Advisors LLC | 0.08% | 16,500 | -68% | 0% | $15,533 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,828,361 | $2,650,830 | +$43,294 | $0.94 | 28 |
| 2026 Q1 | 2,794,557 | $2,066,215 | -$34,998 | $0.75 | 27 |
| 2025 Q4 | 2,851,427 | $2,088,196 | -$35,774 | $0.71 | 30 |
| 2025 Q3 | 2,795,078 | $2,186,394 | +$67,244 | $0.75 | 28 |
| 2025 Q2 | 2,705,418 | $2,337,889 | +$320,116 | $0.88 | 27 |
| 2025 Q1 | 2,338,904 | $1,736,882 | +$874,783 | $0.75 | 23 |
| 2024 Q4 | 1,151,794 | $941,930 | +$711,698 | $0.88 | 12 |